September 24th, afternoon
Jiangsu Productivity Promotion Center
Release of 2024 Jiangsu Unicorn Enterprises and
Gazelle Enterprise Evaluation Results
Singular Medical
Selected for four consecutive years
Jiangsu Potential Unicorn Enterprise
Singular Medical is a leader in the research, development, and production of cardiac rhythm management medical devices in China, committed to creating high-end CRM medical devices for China. The companyThe product line covers Implantable Cardioverter Defibrillators (ICD), Insertable Cardiac Monitors (ICM), CSP pacing systems, and external heart failure monitoring devices. The company has built an elite team consisting of experienced and technically proficient engineers and industry veterans, aiming to provide high-quality and convenient medical products and services to benefit more patients.Singular Medical's domestically produced ICD - Ambulatory® has broken through technical barriers and completed all patient enrollment for clinical trials.This product is fully independently intellectual property rights, capable of achieving automatic pacing, 40J energy charge and discharge, SVT discrimination, streamlined design, and Bluetooth telemetry. Its performance rivals mainstream imported products.And entered the special review process for innovative products of the National Medical Products Administration (Green Channel).Another product of the company, the implantable cardiac monitor (ICM), has full independent intellectual property rights, can accurately detect various types of arrhythmia ECG signals, and features a large ECG storage capacity.As the first ICM in China, the titanium alloy body exhibits excellent biocompatibility. It not only breaks through traditional ICM technical barriers, covering home detection, but also is the first to be equipped with Bluetooth telemetry, supporting real-time cloud transmission via mobile phone and providing more timely diagnosis and treatment assistance functions. This ICM has successfully completed type inspection and animal experiments.Entered the special review process (green channel) for innovative products of the National Medical Products Administration (NMPA), and completed the clinical trials recently.Bed TestAll tests were conducted with complete enrollment and follow-up.In 2022, Singular Medical was rated by the U.S. Medtech Outlook magazine"Best Medical Technology Company in China 2022"，2023Selected" Forbes Asia 100 to Watch ""Enterprise" list,The company's professional capabilities have gained international attention.Company ICD May 2024Product Honored to be Featured"VBEF 2024 Annual Medical Health Industry Innovation Product List", IndustryBoundaryFully affirmed the company's outstanding contributions and remarkable achievements in the medical field.
Looking ahead, Singular Medical will take innovation, quality, and service as its core values, adhere to the concept of "patient-centeredness," continuously improve its technical and service levels, develop products needed for CRM clinical applications, and make outstanding contributions to the cause of human health.Company Profile:
Singular Medical is a hard-tech enterprise focusing on the research, development, and industrialization of medical devices related to Cardiac Rhythm Management (CRM). The company's headquarters is located in the Suzhou High-Tech Zone Medical Device Park, with a 2,800-square-meter manufacturing plant, and offices in Beijing and Irvine, California.MingThe state has established a research and development center. Singular Medical started with the most technically challenging product in the CRM field, the ICD, and has built a complete CRM technology platform. It is growing into a supplier of full-line products in China's CRM field, capable of providing arrhythmia patients with a complete set of solutions from monitoring, diagnosis, treatment to postoperative follow-up.
